Retina
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with retinal vein occlusion; (2) Comply with the syndrome differentiation standard of TCM qi stagnation and blood stasis syndrome, liver yang stagnation syndrome, phlegm and blood stasis syndrome, and Yin deficiency fire phlegm syndrome; (3) The best corrected visual acuity (BCVA) of the target eye is =34 points (the ETDRS visual acuity chart, the visual acuity is equivalent to a score of 20/200, and the decimal is 0.1); (4) Those with an onset within 3 months; (5) Aged between 18 and 65 years; (6) After fully communicating with the patient, the patient voluntarily joined the study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Accompanied by other fundus diseases (such as retinal vein inflammation, glaucoma, diabetic retinopathy, macular degeneration, optic nerve disease, etc.); (2) Opacity of refractive medium is difficult to perform fundus image evaluation; (3) Patients with severe hematopoietic diseases and mental disorders; (4) Pregnant or lactating women; (5) Those who are allergic to the compound tropicamide eye drops; (6) Those who have participated in other clinical trials in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Color fundus photography or super wide-angle retinal laser scanning;Retinal oxygen saturation;intraocular pressure;BCVA;Hemorheological examination;TCM syndrome evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Four diagnostic instruments;Liver and kidney function; | — |
Countries
China
Contacts
Chengdu University of Traditional Chinese Medicine